Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations
NCT: NCT03243019 · RECRUITING
広告
NCT識別子NCT03243019
ステータスRECRUITING
開始日2018-06-25
SponsorUniversity Hospital, Lille (OTHER)
First posted
Last updated
概要
To evaluate the efficacy of Rapamycin in extended cervicofacial lymphatic malformations in pediatric patients. Rapamycin is administered oral for a 6 month period. The success rate is determined by volume reduction superior to 1/5e of the initial volume measured by MRI, impact on QOL and reduction of bleeding in case of mucosal involvement.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。